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Abstract  
The dermal uptake and percutaneous penetration of ten organic flame retardants was measured using an ex 
vivo human skin model. The studied compounds were DBDPE, BTBPE, TBP-DBPE, EH-TBB, BEH-TEBP, 
α, β and  γ-HBCDD as well as syn- and anti-DDC-CO. Little or none of the applied flame retardants was 
recovered in either type of the receptor fluids used (physiological and worst-case). However, significant 
fractions were recovered in the skin depot, particularly in the upper skin layers. The primary effect of the 
worst-case receptor fluid was deeper penetration into the skin. The recovered mass was used to calculate 
lower- and upper-bound permeability coefficients kp. Despite large structural variation between the studied 
compounds, a clear, significant decreasing trend of kp was observed with increasing log Kow. The results 
indicate that the dermis may provide a significant barrier for these highly lipophilic compounds. However, 
based on our results, dermal uptake should be considered in exposure assessments, though it may proceed in 
a time-lagged manner compared to less hydrophobic compounds. 
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1. Introduction 
The ban and phasing out of Penta and Octa mixtures of polybrominated diphenyl ethers (PBDEs) and their 
inclusion in the Stockholm Convention (United Nations, 2009) have potentially led to a shift in use of 
organic flame retardants (FRs) from PBDEs towards alternative flame retardants (Covaci et al., 2011). While 
exposure and effects of PBDEs are relatively well documented (Fromme, 2016; Linares et al., 2015; Lyche et 
al., 2015), few studies on exposure and toxicology of the alternative flame retardants have been published. 
Among the alternatives are decabromodiphenyl ethane  (DBDPE); 1,2-bis(4,2,4-tribromophenoxy) ethane 
(BTBPE); 2,3-dibromopropyl-2,4,6-tribromophenyl ether (TBP-DBPE); 2-ethylhexyl-2,3,4,5-tetrabromo-
benzoate (EH-TBB); bis(2-ethylhexyl)-3,4,5,6-tetrabromophthalate (BEH-TEBP); other related compounds 
of interest include α, β and  γ- hexabromocyclododecane (HBCDD) as well as syn- and anti-Dechlorane Plus 
(DDC-CO), their structure and estimated basic properties are given in Table S1. 
DBDPE has been used as a flame retardant since the early 1990s, with the same commercial applications as 
BDE-209 (Covaci et al., 2011; Kierkegaard et al., 2004) while no information is available on the current 
production and use of TBP-DBPE (Vetter et al., 2010). BTBPE is used to replace OctaBDE (Hoh et al., 
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2005) and can be degraded to 2,4,6-tribromophenol (Hakk et al., 2004), which is an endocrine disrupting 
chemical (Deng et al., 2010). Mixtures containing BEH-TEBP and EH-TBB have been used as replacements 
of PentaBDE (e.g. Firemaster 550), but BEH-TEBP has also been used as a flame retardant on its own 
(Stapleton et al., 2008). It has been demonstrated that BEH-TEBP and EH-TBB have estrogenic disruption 
potential and that metabolites of BEH-TEBP exhibit rodent toxicity (Saunders et al., 2013; Springer et al., 
2012). HBCDD has been recognized as an environmental problem for more than ten years (de Wit, 2002) 
and is now globally regulated through the Stockholm Convention, with exemptions of use in expanded and 
extruded polystyrene in buildings (UNEP, 2013). DDC-CO was introduced in the mid-1960s as a 
replacement flame retardant for Mirex, but unlike Mirex, it has not been used as an insecticide (Hoh et al., 
2006). 
Dermal uptake and percutaneous penetration of topical applied pharmaceuticals are widely studied though 
other chemicals particularly pesticides have also received some attention (WHO, 2006). Dermal uptake is 
most efficient for compounds with a moderate hydrophilicity as well as lipophilicity. This is due to the 
different layers of the skin i.e. the stratum corneum and epidermis generally containing a lot of lipids, while 
the deeper layers contain more water (WHO, 2006). The percutaneous penetration and dermal uptake of 
highly lipophilic compounds (particularly those with log Kow > 7), which includes many of the SVOCs found 
in indoor environments, have only rarely been studied (Zhou et al., 2013). Generally, they have been found 
to accumulate in the skin with limited penetration (Chu et al., 1996; Zhou et al., 2013). The expected 
percutaneous penetration of the studied FRs is low, but since the exposure is continuous uptake and 
penetration may become relevant over time.  
Associations between levels of the better studied PBDEs in indoor dust, hand wipes and biomarkers of 
exposure (breast milk, serum, placenta) have demonstrated that indoor exposure is an important route of 
exposure (Frederiksen et al., 2010; Vorkamp et al., 2011b; Watkins et al., 2011; Wu et al., 2007). Such 
research cannot, however, disentangle the contribution of inadvertent dust ingestion from dermal exposure. 
Modeling suggests that dust ingestion may be the more important of the two for most exposure groups 
(Lorber, 2008; Trudel et al., 2011), but these calculations are hampered by significant uncertainties, for 
example poorly known dust ingestion rates. More recently, the importance of dermal uptake of flame 
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retardants and other semi-volatile organic compounds (SVOCs) via skin contact with products and 
contaminated surfaces as well as direct absorption from indoor air have been discussed as potentially 
significant routes of exposure (Carignan et al., 2013; Weschler and Nazaroff, 2014). For replacement flame 
retardants, we have the additional challenge of little or no data on basic parameters needed to understand 
dermal absorption. The present paper helps fill this gap by providing estimates of dermal uptake and skin 
permeability for a number of the brominated FRs as well as dechlorane plus. 
 
2. Materials and Methods 
2.1. Dermal uptake model 
Human skin was sampled from five female donors (age 33-43 y) that underwent plastic surgery. The donors 
were given complete anonymity and only registered according to age, gender, date of sampling, skin region, 
and size of skin patch. The regional ethics committee was informed about the study and no permission was 
necessary as the skin is considered waste material. The patients had given informed consent prior to skin 
sampling. The skin patches were primarily from the abdominal region, but also back and breast patches were 
used. The skin samples were stored at -20 ºC for periods not exceeding twelve months, which has proven to 
keep the barrier properties of the skin and not significantly change the water permeability (Bronaugh et al., 
1986). The skin was thawed at room temperature and trimmed of subcutaneous fat. Accordingly, full-
thickness skin with a median thickness of 0.8 mm was used.  
Dermal uptake was studied in Franz diffusion cells (Figure 1) as described in OECD guideline 428 (OECD, 
2004). Our system has previously described for dermal uptake of pesticides (Nielsen et al., 2009) and 
pharmaceuticals (Holmgaard et al., 2013). The cells were kept in a water bath ensuring a skin surface 
temperature of approximately 32ºC with continuous individual magnetic stirring. The mean diffusion area 
was 2.64 cm2/cell and the mean receptor chamber volume was 16.6 ml. Two types of receptor fluids were 
used: a physiological relevant receptor fluid (PHY) consisting of an aqueous solution of 0.9% NaCl, 5% 
bovine serum albumin, 40 mg/l hexamycin and Na2HPO4 buffer (to pH 7.4); and a worst-case receptor fluid 
(WOC) consisting of 50% ethanol in water, which is known to increase epidermal permeability significantly 
(Pelling et al., 1997). The worst case receptor fluid was used as an extra measure of penetration since low 
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penetration with the physiological receptor fluid was expected. If nothing was absorbed using the worst case 
receptor, dermal uptake would be considered not to be a significant pathway. After mounting of the skin, 5 
ml isotonic saline was added to the donor chamber and left overnight for hydration of the skin. Before 
starting experiments, the skin integrity was checked by measuring the capacitance (Lutron DM-9023, Acer 
AB, Sweden), which should not exceed 100 nF. After ensuring the integrity of the skin, the isotonic saline 
was removed and the compounds (purchased from Cambridge Isotope Laboratories (HBCDD), purity ≥ 97% 
and Wellington Laboratories (remaining compounds), purity >98%) were added to the donor chamber. At the 
same time the same volume was spiked to laboratory vials (three replicates) to define initial conditions. The 
compounds were loaded in 500 µl ethanol (with 20% isooctane residue) at two levels of 10-100 and 50-300 
ng/cell depending on LOQ of the individual compounds, aiming for positive detection and quantification of 
1% transfer to the receptor fluid at the low level. The cells were covered with parafilm and set in the water 
bath for 72 h; the temperature was checked daily. At the end of the experiment, the residue in the donor 
chamber was collected by gently drying the skin using cotton swabs, then the skin and donor chamber was 
gently washed twice with hexane soaked cotton swabs, and finally the skin was wiped with dry cotton swabs, 
all swaps were collectively analyzed as remains in the donor chamber. Afterwards isotonic saline was again 
added and the capacitance measured to ensure continued barrier integrity. The cells were dismounted and the 
upper skin layers (epidermis) were separated from of the remaining skin fraction (dermis). Finally, the entire 
volume of receptor fluid was sampled, and the chamber was rinsed with approximately 1 ml of fresh receptor 
fluid.  
Figure 1. Composition of Franz diffusion cells.  
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The samples were extracted by sonication, cleaned up on multilayer glass columns and analyzed by either 
GC-MS (ECNI) or LC-MS-MS using previously described methods (Vorkamp et al., 2011a; Vorkamp et al., 
2015). Details on extraction, clean-up, instrumental analysis and detection limits are given in the 
Supplementary material. 
 
2.2. QA/QC  
For every five Franz cells one blank cell was included and only spiked with solvents; it was fractioned into 
the same constituents as the spiked cells and analyzed along with the respective compartments from the test 
cells. The analyzed FRs were rarely detected in the unspiked samples; if detected the levels were very low, 
but the LOQ was raised above the highest blank for the entire batch. In addition, a laboratory blank 
(Hydromatrix®) was included in each batch of samples, here low levels (<LOQ) of TBP-DBPE, BTBPE and 
DDC-CO were occasionally detected. Due to the lack of appropriate SRM material, at least one spiked 
sample of either dermis, epidermis or receptor fluid was used for quality control in each batch. On average, 
the measured amount in the spiked control samples was 109% of the applied amount. The average recovery 
of the analyses (using CB-198 as recovery standard) was 98%, ranging between 73-121%.   
An adhesion test was made to test if some of the applied chemicals were quickly bound to the glass surface 
of the receptor chamber and therefore not available for dermal uptake during the experiment. Five cells were 
set up and spiked with 500 µl of the spike solution as described above, omitting only the receptor fluid; in 
addition one blank spiked with pure solvent was included. The cells were left for 60 min after which excess 
fluid was removed with cotton swaps, followed by washing of the donor cell glass with hexane soaked cotton 
swaps. Following the regular wash, the donor chambers were dismounted and rinsed three times with 
hexane:dichloromethane (1:1 v/v), which was collected. Internal standards were added and the adhesion 
samples were reconstituted and analyzed. On average, 16% of the applied dose stuck to the glass in a way 
that it would not be readily available for dermal uptake, approximately half of this would be sampled along 
with the remaining donor chamber during the regular wash; the variation between the compounds was 
relatively small (Table S2). On average, 70% of the applied dose was still available for uptake (in solution) 
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after 1 h, confirming that actual infinite dosing was present. Detailed results of the adhesion test are given in 
Table S2. 
 
2.3. Calculations 
The flux, J, was calculated as an average flux over the entire experimental period. Furthermore, both a 
lower- and upper-bound flux was calculated based on different assumptions of the fate of the FRs in the skin 
depot. The lower bound flux, Jmin, only considers the absorbed fraction, here defined as the mass recovered in 
the receptor fluid as well as the deeper layers of the skin (dermis). The upper-bound flux, Jmax, includes the 
absorbable dose, which is defined by OECD (OECD, 2004) as the mass of “that present on or in the skin 
following washing” i.e. in the receptor fluid and the entire skin depot (epidermis+dermis). However, the 
depot in the upper layers may either become systemically available with time or be excluded by 
desquamation, therefore, Jmax may be an overestimate of the actual flux through the skin.     
Lower- and upper-bound fluxes, J, were calculated using the following equations:  
(Eq. 1)   𝐽𝑙𝑙𝑙𝑙𝑙 = 𝑎𝑎𝑎𝑙𝑙𝑎𝑙𝑎 𝑎𝑙𝑎𝑙𝐴∙𝑡 = 𝑚𝑆+𝑚𝑅𝐴∙𝑡  
where mS and mR are the mass recovered in deeper skin layers (dermis) and receptor fluid, respectively, A is 
the area for diffusion, and t is the exposure duration.  
(Eq. 2)   𝐽𝑢𝑢𝑢𝑙𝑙 = 𝑎𝑎𝑎𝑙𝑙𝑎𝑎𝑎𝑙𝑙 𝑎𝑙𝑎𝑙𝐴∙𝑡 = 𝑚𝐸+𝑚𝑆+𝑚𝑅𝐴∙𝑡  
where mE is the mass recovered in the upper skin layers (epidermis). 
 
However, since the flux is dependent on the concentration in the donor chamber the permeability coefficient 
kp, as described by Niedorf et al. (2008) was calculated for better comparison between compounds applied in 
different concentrations. In our case it is a pseudo-kp as average and not maximum flux is used. The lower- 
and upper-bound average fluxes resulted in lower- and upper-bound kp values: 
(Eq. 3)  𝑘𝑢,𝑙𝑙𝑙𝑙𝑙 = 𝐽𝑙𝑙𝑙𝑙𝑙𝐶  
(Eq. 4)  𝑘𝑢,𝑢𝑢𝑢𝑙𝑙 = 𝐽𝑢𝑢𝑢𝑙𝑙𝐶  
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where C is the concentration in the donor chamber (as the concentration in the donor chamber far exceeds 
that of the receptor chamber).  
Log Kow at 32°C was calculated using the SPARC online calculator v.6.1. Linear regression and an F-test of 
the slope’s deviation from zero was performed in GraphPad Prism 5. 
 
3. Results  
3.1. Mass distribution and recovery 
The average mass recoveries for the analyzed FRs were between 74-95% of the applied dose, except for 
DBDPE which was 95% and 133% for the two types of receptor fluid. The majority of the recovered FRs 
was found to still be present in the donor chamber (including the wash of the skin) and on average exceeded 
73% of the mass recovered for all compounds in both set-ups (Table 1). This is consistent with the intent of 
having infinite dosing in the experiment. When the physiological receptor fluid was used, the majority of the 
absorbable fraction of the FRs was found in the epidermis (7.9 –11% of applied) and only a smaller fraction 
in the dermis (0.5–1.6%). Using the worst-case receptor fluid resulted in increased deposition in the skin, 
particularly the transport trough the upper skin layers was increased, thus a larger fraction was generally 
found both in the epidermis (10–13%) and particularly in the dermis (1.1–14%) (Table 1). Despite the higher 
uptake still very little (or none) of the applied FR was recovered in the receptor fluid. This was not due to 
limited solubility, as the recovered concentrations (or LOQ in case of non-detects) were less than 5% of the 
soluble amount for all compounds in the WOC receptor fluid (Table S3). Due to the BSA present in PHY 
receptor fluid it was not possible to make a good estimate of the solubility, but it will exceed that of pure 
water (Table S3). 
 
3.2. Permeability coefficients, kp 
The lower- and upper-bound kps for both types of receptor fluid are shown in Table 2. For the physiological 
receptor fluid, upper-bound kp -values were generally one order of magnitude higher than the lower-bound 
estimates. In case of the worst-case receptor fluid the differences were smaller. Figure 2 shows the upper-
bound kp plotted against log Kow at 32°C, a significant decreasing trend (p<0.0001) was observed for both 
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types of receptor fluid, indicating reduced dermal uptake with increasing log Kow for these highly lipophilic 
compounds. The same trend was observed for the lower bound kp-values of both receptor fluids, though with 
larger variation (Figure S1).  
 
Table 1. Mean distribution of FRs in different compartments (percent of total detected amount) after 72h in Franz cells. Mass 
recovery was calculated relative to the applied dose. For receptor fluids the detection frequency is given in parentheses, for all other 
compartments the detection frequency was 100%. Values <LOQ were set to LOQ in calculations. 
 Physiological receptor fluid (n=5) Worst-case receptor fluid (n=13) 
 
Donor 
chamber 
Epi-
dermis Dermis 
Receptor 
fluid 
Mass 
recovery 
Donor 
chamber 
Epi-
dermis Dermis 
Receptor 
fluid 
Mass 
recovery 
TBP-
DBPE 87% 11% 1.6% 
< 0.1% 
(0%) 95% 73% 13% 14% 0.2% (15%) 87% 
EH-TBB 89% 10% 0.6% 0.2% (20%) 89% 83% 13% 4.3% < 0.05% (0%) 82% 
BTBPE 89% 10% 0.7% 0.1% (20%) 89% 84% 12% 3.6% 0.1% (8%) 83% 
DBDPE 88% 10% 1.0% < 0.5% (0%) 133% 84% 12% 3.2% 
< 0.6% 
(0%) 95% 
BEH-
TEBP 90% 9.5% 0.5% 
0.04% 
(40%) 89% 88% 11% 1.1% 
0.03% 
(23%) 81% 
syn DDC-
COa 91% 8.4% 0.5% 
< 0.1% 
(0%) 87% 85% 13% 2.2% 0.1% (29%) 74% 
anti DDC-
COa 91% 7.9% 0.8% 0.2% (33%) 90% 85% 12% 2.7% 0.2% (57%) 74% 
α-HBCDD 88% 11% 1.0% 0.1% (40%) 89% 85% 12% 2.5% 0.1% (54%) 79% 
β-HBCDD 88% 11% 0.8% 0.1% (40%) 90% 84% 12% 3.7% 0.03% (31%) 79% 
γ-HBCDD 89% 10% 0.8% 0.1% (40%) 86% 87% 10% 2.8% 0.1% (15%) 76% 
aFor syn- and anti DDC-CO n=3 for physiological receptor fluid and n=7 for worst case receptor fluid.  
 
 
Table 2. Lower and upper bound permeability coefficient, kp, for physiological (PHY) (n=5) and worst case (WOC) 
receptor fluid (n=13) 
 
Lower bound 
kp(PHY) 
[10-4 cm/h] 
Upper bound kp 
(PHY) 
[10-4 cm/h] 
Lower bound 
kp(WOC) 
[10-4 cm/h] 
Upper bound 
kp(WOC) 
[10-4 cm/h] 
TBP-DBPE 0.38 3.1 3.3 6.2 
EH-TBB 0.16 2.5 0.92 3.7 
BTBPE 0.16 2.4 0.71 3.1 
DBDPE 0.11 2.2 0.42 2.5 
BEH-TEBP 0.13 1.4 0.32 1.6 
syn DDC-COa 0.11 1.9 0.39 2.6 
anti DDC-COa 0.16 1.8 0.46 2.6 
α-HBCDD 0.22 2.7 0.52 3.1 
β-HBCDD 0.17 2.5 0.76 3.2 
γ-HBCDD 0.15 2.3 0.55 2.5 
aFor syn- and anti DDC-CO n=3 for physiological receptor fluid and n=7 for worst case receptor fluid.  
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Figure 2. Log Kow at 32°C and upper-bound kp (mean ± SEM) for PHY receptor fluid (n=5) and WOC receptor fluid 
(n=13) (for DDC-COs n=3 and 7 for PHY and WOC, respectively).
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4. Discussion  
4.1. Mass distribution and recovery 
We estimated skin deposition and permeability for ten organic flame retardants using an ex-vivo human skin 
model. Despite the low levels applied, the mass recovery was >74% and high consistency between cells was 
observed, proving the strengths of the model and analytical procedure for the purpose of this study.   
In our experiments, there were little or no detectable levels of the target compounds in the receptor fluid, 
even following 72 h. Our results indicated that FRs were absorbed into the skin—about 10% for many 
compounds—with most of each compound in the epidermis and about an order of magnitude less in the 
dermis. The effect of the WOC receptor fluid was primarily that the compounds were deposited deeper in the 
skin (at 72 h) while percutaneous penetration did not increase markedly. This is in line with a study of 
another highly lipophilic compound (DEHP) on separated epidermis and dermis, finding that transport across 
the epidermis is greatly increased using 50% ethanol/water compared to a buffered saline receptor fluid 
while the effect on transport across the dermis is modest (Pelling et al., 1997). Stratum corneum is generally 
considered the main barrier for percutaneous penetration (Hadgraft, 2004), but for highly lipophilic 
compounds, like the FRs in the current study, the dermis and viable epidermis may provide a significant 
barrier and temporary site for deposition and subsequent systemic absorption due to their hydrophilic nature 
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(Nielsen et al., 2009). Similarly, Zhou et al. (2013) studied the percutaneous penetration di(2-ethylhexyl) 
adipate, which is structurally very different from the FRs but with similar log Kow (8.1) and found the 
majority of the absorbable dose present in the skin depot and very little in the receptor fluid.  
 
4.2. Permeability coefficients, kp 
The fraction absorbed may depend on experimental conditions such as skin loading and use of these numbers 
in risk assessments can be misleading (Kissel, 2011). The physical paradigm for the ex vivo skin experiments 
is that of gradient-driven diffusion across the skin. As a result, we are more interested in flux and the skin 
permeability coefficient than fraction absorbed. Traditionally, only the fraction in the receptor fluid would be 
considered when calculating kp (Niedorf et al., 2008), but for highly lipophilic compounds like these FRs it 
may not be the most relevant measure, as the compounds may be temporarily retained either in the skin (Díez 
Sales et al., 1993) or in remaining subcutaneous fat and may therefore not reach the receptor fluid during the 
time span of the experiment. Slowly absorbed compounds such as our target compounds may be eliminated 
via desquamation or other mechanisms such as metabolism. Rather than representing steady state, our flux 
and kp estimates are instead an average over the experimental time period and do not take the potential lag 
time into account, which is expected to be substantial for these compounds as lag time has been found to 
increase with molecular weight (MW) (Nielsen et al., 2009).  The average flux into the dermis and receptor 
fluid will tend to underestimate the steady-state flux, while the average flux into the epidermis may 
overestimate the steady-state flux (Cleek and Bunge, 1993). Taking these factors into account, we believe 
that our estimates of skin permeability (computed from average flux) represent lower and upper bounds. 
However, the water-rich dermis will for the studied compounds provide a significant barrier, whereas in vivo 
blood will also perfuse the lower regions of the epidermis and transport the chemicals to the blood stream, 
therefore we believe the upper-bound kp is closer to the true value of kp than the lower-bound.  
There are very few other data on ex vivo skin experiments for this type of compounds. Abdallah et al. (2015) 
reported kp values of 2.16×10-4, 1.47×10-4 and 1.37×10-4 cm/hr for α-, β- and γ-HBCDD, respectively, and 
found similar results using 3D-human skin equivalents. These are within a factor of two of our upper-bound 
estimates for the same compounds. Often it is difficult to compare absolute numbers from different 
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laboratories using different setups, but the rank order is expected to be the same (van de Sandt et al., 2004). 
Abdallah et al. (2015) were able to achieve steady state and computed their estimates based on mass in the 
receptor fluid. There may be other differences between the two experiments, for example, skin thickness or 
fat remaining in the skin, which may increase the retention of lipophilic compounds. Although we removed 
as much underlying fat as we could from our samples before mounting them in the diffusion cells, taking 
care not to damage the skin, traces of fat may remain. Abdallah et al. state that their skin samples were “full 
thickness without adipose tissue” with an average thickness of 550 µm compared to 800 µm in the current 
study. Despite these potential differences in experimental set-ups, the rank order of estimated permeability 
for the three HBCDDs is the same in both experiments. 
Hughes et al. (2001)  used mice skin to study the uptake of BDE-209, which has a very similar MW and log 
Kow as well as structural resemblance to DBDPE tested in the current study. Hughes et al. found that the 
majority of the absorbable dose was recovered in the skin depot rather than in the receptor fluid after 24 h, 
which agrees with our findings for DBDPE.  
 
Despite great structural differences of the FRs included in the current study a clear, significant decreasing 
trend of kp with increasing log Kow was observed. For the HBCDDs a single value of  log Kow (at 32°C) was 
computed using SPARC, however experimental data suggest that log Kow increases in the order α-HBCDD < 
β-HBCDD < γ-HBCDD (Hayward et al., 2006). Thus the individual HBCDD isomers also fit the overall 
trend of decreasing kp with increasing log Kow (Table 2). 
There are a number of models, both biologically and QSAR-based, for predicting skin permeability using the 
physical chemical properties of the compounds, as the DERMWIN module of the USEPA model EPIsuite 
(US EPA, 2004). The DERMWIN estimates are based on a modification of the classic Potts and Guy model 
(Potts and Guy, 1992), a QSAR model using log Kow and MW, though the coefficients of the regression 
equation have been modified using additional chemical data (US EPA, 2004). There are several reasons not 
to use the DERMWIN permeability estimates in our case. The Potts and Guy model is designed to model 
permeability of the stratum corneum, but as discussed above viable epidermis and dermis may provide the 
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main barrier for highly lipophilic compounds.  Thus, the log Kow and MW for the compounds we studied are 
outside the “effective predictive range” of DERMWIN (US EPA, 2004). Instead, skin can be modeled as 
resistors in series (with permeability inversely related to resistance) (Díez Sales et al., 1993; Weschler and 
Nazaroff, 2012). The effect of the skin layers on penetration of highly lipophilic compounds is well 
illustrated by Diez-Sales et al. showing an optimum kp at log Kow of approximately 3.5 (Díez Sales et al., 
1993). Similarly, Nielsen et al. (2009) found that above a log Kow of 2 no further increase in kp was observed 
for a number of pesticides. Another interesting approach to this problem is that of Bunge et al. (1995) who 
developed methods for estimating the ratio of the permeability in the stratum corneum to that of the viable 
epidermis. When this ratio (B) is less than about 0.1, the resistance of the stratum corneum dominates. 
Following the procedure in Weschler and Nazaroff (2012), we calculated values of B for the compounds in 
our data set: all were above 0.1, some much higher (data not shown). However, these estimates of B also 
depend on the estimate of the stratum corneum permeability. The latter was computed using the model of 
Mitragotri (2002), which is mechanistic rather than a QSAR (although its final mathematical form also relies 
on log Kow and MW); it predicts stratum corneum permeability better than a number of alternatives (Lian et 
al., 2008). The physical assumptions of the Mitragotri model may break down for MW>400, which includes 
all of the compounds we studied. Additional research is needed on the applicability of models for predicting 
skin permeability of the types of compounds in our study. 
  
4.3. Strengths and weaknesses 
The current study did not investigate the kinetics of the dermal uptake due to the low levels found in the 
receptor fluid at termination. Kinetic information could only be obtained by sacrificing entire cells during the 
experiment, which we did not find feasible. Furthermore, as a consequence of using non-viable skin the 
effect of metabolism was not included. However, for these very persistent compounds, metabolism is 
expected to be of minor importance i.e. Abdallah et al. (2015) had a similar mass recovery of the parent 
HBCDDs using viable skin, indicating that metabolism is negligible. The strength of our study is the use of 
full-thickness human skin, which means that no extrapolation between species is necessary. In addition, the 
experimental design and protocol followed those of previous studies (Nielsen et al., 2004; 2009; 2010; 
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Nielsen and Nielsen, 2000) on skin uptake and penetration of organic chemicals, allowing comparisons 
between compounds of different physical-chemical properties. Furthermore, the ethical implications of using 
the skin, which is considered waste, are minimal. In the current study all calculations were done at the 
relevant temperature rather than the reference temperature.  
 
4.4. Implications for dermal exposure 
The current study indicates that the included FRs can be taken up via dermal absorption. Though little of the 
applied amount was recovered in the receptor fluid, the skin depot, which may eventually become available, 
was noteworthy. In the skin depot, the largest fraction was found in the upper skin layers – from there it can 
either penetrate deeper or be eliminated, for example via desquamation or hand washing. The relative 
importance of the two depends on the time scale on which they occur; in the current study no information on 
lag time was available, but in real life the exposure is likely to be continuous. Again, more data are available 
for PBDEs and pesticides. Watkins et al. (2011)  showed that increased handwashing frequency is associated 
with lower serum levels – indicating that PBDEs to some extent can be washed off the skin. Likewise, 
experimental studies on four model compounds have demonstrated that skin cleansing within 6 h of exposure 
significantly reduce skin permeation (Nielsen, 2010). Thus, from a preventive point of view, more FRs with 
potential toxicity may need to be phased out or exposures should be reduced, but in the meantime secondary 
prevention based on increased hygienic precautions may help. The question how the compound application 
in the study relates to contact to these compounds in dust, products or air warrants further research. 
 
5. Conclusion 
Dermal uptake but little or no percutaneous penetration was observed for all the studied FRs. The permeation 
was found to decrease linearly with increasing log Kow despite the structural diversity of the compounds. 
Continuous dermal exposure to FRs at the skin surface may lead to dermal uptake and possibly eventually 
percutaneous penetration though this would proceed in a time lagged manor.  
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Supplementary Material 
 
Extraction, clean-up and analysis of FRs 
The samples were analysed in the following way: Donor chamber (D), epidermis (E) and dermis (S)-samples 
were extracted by sonication for 30min with 10ml hexane:dichloromethane (1:1) two times using fresh 
solvent. Extracts from donor and epidermis samples were evaporated and cleaned up on a glass column 
packed with 2 g Al2O3 (10% H2O), 2 g silica and Na2SO4 and eluted with 60 ml hexane: dichloromethane 
(1:1). However, some dermis samples contained lipid residues and required better clean-up, on the other 
hand BEH-TEBP as is not stable in strong acid, therefore in a subset of samples we chose to divide the 
extracts for two different types of clean-up. 50% of the extract was cleaned up using the column described 
above and analysed for BEH-TEBP using 13C-BEH-TEBP as internal standard. The other 50% of the extract 
were cleaned up in a column packed with 5 g Al2O3 (10% H2O), 5 g silica impregnated with 40% sulphuric 
acid, 2 g silica topped with 1 cm anhydrous Na2SO4 and eluted with 250ml hexane: dichloromethane (1:1), 
which is identical to the H2SO4 containing column clean-up previously used for NBFRs in biota (Vorkamp et 
al., 2015). The receptor fluid was dried with Hydromatrix® and extracted using Soxhlet extraction as 
described for PBDEs (Vorkamp et al., 2004a; 2004b), followed by the simple column clean-up described 
above. After clean-up, the extracts were divided for GC-MS and LC-MS-MS analysis in the following way: 
50% was evaporated to dryness and reconstituted in 25 0 µl methanol; the other half was evaporated to 
dryness in silicone coated vials (Vorkamp et al., 2014) and reconstituted in 200 µl isooctane. D-samples 
were also analysed in dilution. DBDPE, BTBPE, TBP-DBPE, EH-TBB, BEH-TEBP as well as syn- and anti-DDC-
CO were analysed by GC-MS (ECNI) while HBCDDs were analysed by LC-MS-MS as previously described 
(Vorkamp et al., 2015). The LOQs of the method are given in Table S4. 
  
 20 
 
 
Table S1. Structure, CAS number, molecular weight (MW) and calculated log Kow at 32°C for the flame 
retardants included in the study. 
 CAS number Structure MW (g/mol) Log Kow at 32°Ca 
TBP-DBPE 35109-60-5 O Br
BrBr
Br
Br
 
530.7 6.43 
EH-TBB 183658-27-7 
O
O
CH3
CH3
Br
Br
Br
Br
 
549.9 8.25 
BTBPE 37853-59-1 OO
Br Br
Br
Br
BrBr  
687.6 9.41 
DBDPE 84852-53-9 
Br
Br
Br
Br
Br
Br
Br
Br
Br
Br
 
971.2 11.96 
BEH-TEBP 26040-51-7 
O
O
Br
BrBr
Br
O
O
 
706.21 11.04 
syn-DDC-CO 
13560-89-9 
Cl
ClCl
Cl
Cl Cl
Cl
Cl
Cl
Cl
Cl Cl
 653.7 11.11b 
anti-DDC-CO 
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
 
α-HBCDD 134237-50-6 
Br
Br
Br
Br
BrBr  
641.7 6.78b β-HBCDD 134237-51-7 
γ-HBCDD 134237-52-8 
aLog KOW calculated using the SPARC online calculator v.6.1  bCalculations in SPARC do not distinguish 
between isomers.  
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Table S2. Detailed results of adhesion test. Mean (± standard deviation) as percent of applied dose (n=5).  
 Available in solution 
Washable from 
glass surfaces 
Remains adhered 
on glass after 
washing 
Mass recovery 
(excl. skin depot) 
TBP-DBPE 73% ± 3% 8% ± 1% 7% ± 2% 88% ± 3% 
EH-TBB 70% ± 3% 10% ± 1% 7% ± 2% 87% ± 5% 
BTBPE 67% ± 2% 8% ± 1% 7% ± 2% 82% ± 2% 
DBDPE 65% ± 19% 11% ± 11% 9% ± 8% 85% ± 31% 
BEH-TEBP 73% ± 5% 10% ± 2% 7% ± 2% 90% ± 8% 
syn DDC-CO 65% ± 2% 8% ± 2% 6% ± 2% 79% ± 1% 
anti DDC-CO 65% ± 2% 8% ± 2% 6% ± 2% 79% ± 2% 
α-HBCDD 73% ± 3% 8% ± 3% 10% ± 2% 91% ± 5% 
β-HBCDD 73% ± 2% 7% ± 2% 9% ± 2% 89% ± 3% 
γ-HBCDD 76% ± 5% 7% ± 2% 10% ± 2% 93% ± 5% 
 
 
Table S3. Estimated solubility of FRs in water and WOC receptor fluid (water:ethanol, 1:1 vol) at 32C (SPARC 
online calculator v.6.1) 
 Solubility in water at 32C (mg/L) 
Solubility in WOC at 32C 
(mg/L) 
Measured concentration 
relative to solubility 
(WOC)a 
TBP-DBPE 8.1E-03 7.8E-01 0.001% 
EH-TBB 5.4E-05 4.1E-02 0.01% 
BTBPE 7.1E-07 5.8E-04 1% 
DBDPE 2.5E-11 2.8E-04 5% 
BEH-TEBP 1.1E-08 8.4E-05 5% 
syn DDC-CO 1.7E-07 1.2E-03 0.3% anti DDC-CO 
α-HBCDD 
7.7E-04 2.0E-01 0.001% β-HBCDD 
γ-HBCDD 
a<LOQ was replaced with LOQ 
 
Table S4. Limit of quantification (LOQ) of FRs 
 General LOQ  (ng/sample) 
Corresponding LOQ of 
receptor fluid 
(mg/L)a 
TBP-DBPE 0.1b 6,0E-06 
EH-TBB 0.1 6,0E-06 
BTBPE 0.25 1,5E-05 
DBDPE 0.25 1,5E-05 
BEH-TEBP 0.1 6,0E-06 
syn DDC-CO 0.2b 1,5E-05 
anti DDC-CO 0.2b 1,5E-05 
α-HBCDD 0.1 6,0E-06 
β-HBCDD 0.1 6,0E-06 
γ-HBCDD 0.1 6,0E-06 
ausing average receptor chamber volume belevated above the highest blank.  
 22 
 
 
Figure S1. Log Kow at 32°C and lower-bound kp (mean ± SEM) for PHY receptor fluid (n=5) and WOC receptor 
fluid (n=13) (for DDC-COs n=3 and 7, respectively). 
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